Chronic Constipation - Epidemiology Forecast - 2032

January 2022 | 60 pages | ID: CA2777E0BA48EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Chronic Constipation - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Chronic Constipation epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Chronic Constipation Understanding

The DelveInsight Chronic Constipation epidemiology report gives a thorough understanding of the Chronic Constipation by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Chronic Constipation in the US, Europe, and Japan. The report covers the detailed information of the Chronic Constipation epidemiology scenario in seven major countries (US, EU5, and Japan).

Chronic Constipation Epidemiology Perspective by DelveInsight

The Chronic Constipation epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Chronic Constipation epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Chronic Constipation epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Chronic Constipation Detailed Epidemiology Segmentation

The Chronic Constipation epidemiology covered in the report provides historical as well as forecasted Chronic Constipation epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Chronic Constipation report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Chronic Constipation report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Chronic Constipation Epidemiology Report and Model provide an overview of the global trends of Chronic Constipation in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Chronic Constipation in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Chronic Constipation
• The report provides the segmentation of the Chronic Constipation epidemiology

Report Highlights

• 11-year Forecast of Chronic Constipation epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Chronic Constipation
• Cases of Chronic Constipation by Mutation Types
• Chronic Constipation Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Chronic Constipation?
• What are the key findings pertaining to the Chronic Constipation epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Chronic Constipation across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Chronic Constipation?
• What are the currently available treatments of Chronic Constipation?

Reasons to buy

The Chronic Constipation Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Chronic Constipation market
• Quantify patient populations in the global Chronic Constipation market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Chronic Constipation therapeutics in each of the markets covered
• Understand the magnitude of Chronic Constipation population by its epidemiology
• The Chronic Constipation Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF CHRONIC CONSTIPATION

3. CHRONIC CONSTIPATION: DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Chronic Constipation Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Chronic Constipation Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Chronic Constipation Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Chronic Constipation Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Chronic Constipation Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Chronic Constipation Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Chronic Constipation Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Chronic Constipation Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Chronic Constipation Treatment and Management
6.2. Chronic Constipation Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Chronic Constipation Epidemiology in 7MM (2019-2032)
Table 2: Chronic Constipation Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Chronic Constipation Epidemiology in the United States (2019-2032)
Table 4: Chronic Constipation Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Chronic Constipation Epidemiology in Germany (2019-2032)
Table 6: Chronic Constipation Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Chronic Constipation Epidemiology in France (2019-2032)
Table 8: Chronic Constipation Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Chronic Constipation Epidemiology in Italy (2019-2032)
Table 10: Chronic Constipation Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Chronic Constipation Epidemiology in Spain (2019-2032)
Table 12: Chronic Constipation Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Chronic Constipation Epidemiology in the United Kingdom (2019-2032)
Table 14: Chronic Constipation Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Chronic Constipation Epidemiology in Japan (2019-2032)
Table 16: Chronic Constipation Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Chronic Constipation Epidemiology in 7MM (2019-2032)
Figure 2 Chronic Constipation Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Chronic Constipation Epidemiology in the United States (2019-2032)
Figure 4 Chronic Constipation Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Chronic Constipation Epidemiology in Germany (2019-2032)
Figure 6 Chronic Constipation Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Chronic Constipation Epidemiology in France (2019-2032)
Figure 8 Chronic Constipation Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Chronic Constipation Epidemiology in Italy (2019-2032)
Figure 10 Chronic Constipation Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Chronic Constipation Epidemiology in Spain (2019-2032)
Figure 12 Chronic Constipation Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Chronic Constipation Epidemiology in the United Kingdom (2019-2032)
Figure 14 Chronic Constipation Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Chronic Constipation Epidemiology in Japan (2019-2032)
Figure 16 Chronic Constipation Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report